Identifying protein–protein interaction networks can reveal therapeutic targets in cancer; however, for heterogeneous cancers such as colorectal cancer (CRC), a pooled analysis of the entire dataset may miss subtype-specific mechanisms, whereas separate analyses of each subgroup’s data may reduce the power to identify shared relations. To address this limitation, we propose a hierarchical Bayesian model for the inference of dependency networks that encourages the common selection of edges across subgroups while allowing subtype-specific connections. To allow for nonlinear dependence relations, we rely on Bayesian Additive Regression Trees (BART) to characterize the key mechanisms for each subgroup. Because BART is a flexible model that allows nonlinear effects and interactions, it is more suitable for genomic data than classical models that assume linearity. To connect the subgroups, we place a Markov random field prior on the probability of utilizing a feature in a splitting rule; this allows us to borrow strength across subgroups in identifying shared dependence relations. We illustrate the model using both simulated data and a real data application on the estimation of protein–protein interaction networks across CRC subtypes.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: